Asbaghi, O., Ghanbari, N., Shekari, M., Reiner, ., Amirani, E., Hallajzadeh, J., Mirsafaei, L., & Asemi, Z
As with other incretin-based therapies, retatrutide is associated with a range of side effects, the majority of which are gastrointestinal in nature and tend to be most pronounced during the dose-escalation phase
These get you in trouble fast: Copying protocols from forums without medical director signoff Buying from gray-market suppliers Leaving the medical director out of key decisions Making big, unsupported claims in your marketing Skipping patient consent or not documenting it well Forgetting to track lot numbers and product info Letting non-clinical staff answer medical questions Ignoring your state's rules on scope and compliance Mistake: Treating Peptides Like Retail Wellness Items Even with high demand, peptides aren't just supplements or retail items for your shelf
Some expanded panels add benzodiazepines, barbiturates, and methadone
131 , e139434 (2021)